Targeting immune cells that help tumors stay hidden could improve immunotherapy

Researchers at University of Pittsburgh School of medicine and UPMC have discovereda clue that could unlock the potential of immunotherapy drugs to successfully treat more cancers. The finding, published in Cell, were made in mice and showed that targeting a sub-population of immune cells called regulatory T cells could be an effective approach of treating cancers. The findings also point ot what could be an importnat mechanism by which current immunotherapy drugs work, providing clues to making them more effective. 

See original article at: https://www.sciencedaily.com/releases/2017/06/170615120605.htm